Syner-G BioPharma Group is the premier solution provider of Chemistry, Manufacturing, and Controls (CMC) services for the life sciences industry. The company’s approach is based on CMC 360™, a fully integrated suite of CMC solutions that encompasses pharmaceutical development, regulatory affairs, and quality/cGxP compliance. The entire Syner-G organization is built around the premise of guiding small molecule, biologics, cell and gene therapy, and medical device innovators through the CMC process.
Since its founding in 2007, Syner-G has enabled clients in their quest to bring life-saving and life-enhancing products to patients. Today, the company has grown to more than 100 employees globally, been recognized as one of the “Top 10 Drug Development and Consulting Services Companies” by Pharma Tech Outlook, and served as an integral part of more than 500 various types of successful regulatory filings. For customers looking for offshore resources, Syner-G also offers CMC services based in India. Syner-G’s operations in India follow the same CMC 360™ model used in the U.S., further differentiating the company from typical CMC consultants.
Since its founding in 2007, Syner-G has enabled clients in their quest to bring life-saving and life-enhancing products to patients. Today, the company has grown to more than 100 employees globally, been recognized as one of the “Top 10 Drug Development and Consulting Services Companies” by Pharma Tech Outlook, and served as an integral part of more than 500 various types of successful regulatory filings. For customers looking for offshore resources, Syner-G also offers CMC services based in India. Syner-G’s operations in India follow the same CMC 360™ model used in the U.S., further differentiating the company from typical CMC consultants.
Location: United States, Massachusetts, Southborough
Employees: 51-200
Founded date: 2007
Investors 1
| Date | Name | Website |
| - | Riverside ... | riversidep... |
Mentions in press and media 12
| Date | Title | Description |
| 23.10.2025 | From Science to Success: Syner-G Announces New Brand & Service Model to Drive Biopharma Innovation | New Positioning Strengthens Commitment to End-to-End Biopharma Development Solutions BOSTON, Oct. 23, 2025 /PRNewswire-PRWeb/ -- Syner-G has unveiled a new brand and service delivery model to accelerate biopharmaceutical product development... |
| 25.06.2025 | Sequoia Biotech Consulting Rebrands as Syner-G BioPharma Group | Syner-G BioPharma Group Unified Identity Strengthens Commitment to End-to-End Biopharma Development Solutions BOSTON, June 25, 2025 /PRNewswire-PRWeb/ -- Sequoia Biotech Consulting (Sequoia) has officially rebranded as Syner-G BioPharma Gro... |
| 08.04.2025 | Syner-G BioPharma Group and Sequoia Biotech Consulting Name Scott Bergeron as Chief Commercial Officer | Scott Bergeron Experienced commercial leader to drive strategic growth and client success BOSTON, April 8, 2025 /PRNewswire-PRWeb/ -- Syner-G BioPharma Group (Syner-G) and Sequoia Biotech Consulting (Sequoia), a leading provider of integrat... |
| 04.03.2025 | Syner-G BioPharma Group & Sequoia Biotech Consulting appoint Chris Erickson as Chief Operating Officer | Sequoia Biotech Consulting & Syner-G BioPharma Group Industry veteran brings decades of experience to drive operational excellence BOSTON, March 4, 2025 /PRNewswire-PRWeb/ -- Syner-G BioPharma Group (Syner-G) & Sequoia Biotech Consu... |
| 18.09.2024 | Sequoia Biotech Consulting and Syner-G BioPharma Group Announce Strategic Combination | Sequoia+Syner-G Two Leading Consultancies Unite to Deliver Comprehensive, Integrated Solutions for Life Science Organizations Worldwide BOSTON, Sept. 18, 2024 /PRNewswire-PRWeb/ -- Sequoia Biotech Consulting (Sequoia), a leading life scienc... |
| 26.10.2023 | Kristin Murray Joins Syner-G BioPharma Group as Senior Vice President of Regulatory Services | Syner-G BioPharma Murray to Spearhead Newly Integrated Department I’m absolutely thrilled to welcome Kristin into the Syner-G family.” — Ron KrausBOSTON, MASSACHUSETTS, UNITED STATES, October 26, 2023 /EINPresswire.com/ -- Syner-G BioPharma... |
| 06.04.2023 | Syner-G Biopharma Group Announces Neil Butera as New Chief Commercial Officer | BOSTON (PRWEB) April 06, 2023 Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, today announced the addition of Neil Bu... |
| 24.01.2023 | Riverside Partners’ Portfolio Company Syner-G Acquires RMC | Boston, MA, January 24, 2023 - Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, has acquired RMC Ph... |
| 19.01.2023 | Syner-G BioPharma Group Acquires RMC Pharmaceutical Solutions | BOSTON (PRWEB) January 19, 2023 Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, today announced the acquisition of RM... |
| 10.01.2023 | Syner-G Biopharma Group Announces Karen Casey as Chief People Officer | BOSTON (PRWEB) January 10, 2023 Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to the pharmaceutical and medical device industries, today announced that Karen Ca... |
Show more